These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 23118928)
21. Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch. Chen L; Li Q; Zheng Z; Xie J; Lin X; Jiang C; Xu H; Wu X; Wu J; Zhang H Chem Biol Drug Des; 2019 Jul; 94(1):1368-1377. PubMed ID: 30873716 [TBL] [Abstract][Full Text] [Related]
22. Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines. Bertazza L; Barollo S; Mari ME; Faccio I; Zorzan M; Redaelli M; Rubin B; Armanini D; Mian C; Pezzani R Molecules; 2019 Jun; 24(12):. PubMed ID: 31212829 [TBL] [Abstract][Full Text] [Related]
23. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2. Zhang P; Bai H; Liu G; Wang H; Chen F; Zhang B; Zeng P; Wu C; Peng C; Huang C; Song Y; Song E Toxicol Lett; 2015 May; 234(3):151-61. PubMed ID: 25725129 [TBL] [Abstract][Full Text] [Related]
25. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. Thomas SL; Zhong D; Zhou W; Malik S; Liotta D; Snyder JP; Hamel E; Giannakakou P Cell Cycle; 2008 Aug; 7(15):2409-17. PubMed ID: 18682687 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of QHF-cisplatin against hepatocellular carcinoma in a mouse model. Chen T; Yuan SJ; Wang J; Hu W World J Gastroenterol; 2015 Sep; 21(35):10126-36. PubMed ID: 26401077 [TBL] [Abstract][Full Text] [Related]
27. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model. Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167 [TBL] [Abstract][Full Text] [Related]
28. Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic" Bakalova R; Zhelev Z; Shibata S; Nikolova B; Aoki I; Higashi T Anticancer Res; 2017 Oct; 37(10):5449-5458. PubMed ID: 28982855 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors. Jin R; Chen Q; Yao S; Bai E; Fu W; Wang L; Wang J; Du X; Wei T; Xu H; Jiang C; Qiu P; Wu J; Li W; Liang G Eur J Med Chem; 2018 Jan; 144():218-228. PubMed ID: 29351887 [TBL] [Abstract][Full Text] [Related]
30. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction. Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705 [TBL] [Abstract][Full Text] [Related]
31. The epigallocatechin gallate derivative Y Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759 [TBL] [Abstract][Full Text] [Related]
32. Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous cell carcinoma. Lin C; Tu C; Ma Y; Ye P; Shao X; Yang Z; Fang Y Mol Med Rep; 2017 Oct; 16(4):4927-4933. PubMed ID: 28791378 [TBL] [Abstract][Full Text] [Related]
33. Sodium orthovanadate inhibits growth of human hepatocellular carcinoma cells in vitro and in an orthotopic model in vivo. Wu Y; Ma Y; Xu Z; Wang D; Zhao B; Pan H; Wang J; Xu D; Zhao X; Pan S; Liu L; Dai W; Jiang H Cancer Lett; 2014 Aug; 351(1):108-16. PubMed ID: 24858025 [TBL] [Abstract][Full Text] [Related]
34. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects. Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336 [TBL] [Abstract][Full Text] [Related]
35. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway. Hong SW; Jung KH; Lee HS; Choi MJ; Son MK; Zheng HM; Hong SS Cancer Sci; 2012 Nov; 103(11):1929-37. PubMed ID: 22909393 [TBL] [Abstract][Full Text] [Related]
36. Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer. Chen X; Dai X; Zou P; Chen W; Rajamanickam V; Feng C; Zhuge W; Qiu C; Ye Q; Zhang X; Liang G Br J Pharmacol; 2017 May; 174(10):1131-1146. PubMed ID: 28255993 [TBL] [Abstract][Full Text] [Related]
37. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo. Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661 [TBL] [Abstract][Full Text] [Related]
38. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling. Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455 [TBL] [Abstract][Full Text] [Related]
39. The Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells. He Y; Li W; Zhang J; Yang Y; Qian Y; Zhou D Curr Cancer Drug Targets; 2021; 21(7):608-618. PubMed ID: 33655859 [TBL] [Abstract][Full Text] [Related]
40. Saponins isolated from Schizocapsa plantaginea inhibit human hepatocellular carcinoma cell growth in vivo and in vitro via mitogen-activated protein kinase signaling. Sun YW; Qiu HC; Ou MC; Chen RL; Liang G Chin J Nat Med; 2018 Jan; 16(1):29-40. PubMed ID: 29425588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]